Antioxidant capacity of hesperidin from Citrus peel using electron spin resonance and cytotoxic activity against human carcinoma cell lines

被引:95
作者
Al-Ashaal, Hanan A. [1 ]
El-Sheltawy, Shakinaz T. [2 ]
机构
[1] Natl Res Ctr, Res Drugs & Pharmaceut Ind Div, Giza, Egypt
[2] Cairo Univ, Dept Chem Engn, Fac Engn, Cairo, Egypt
关键词
FLAVONOIDS; QUERCETIN; DIOSMIN;
D O I
10.3109/13880209.2010.509734
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
Objective: The aim of the study is the isolation of hesperidin from the peel of Citrus sinensis L. (Rutaceae), and the evaluation of its antioxidant capacity and cytotoxicity against different human carcinoma cell lines. Materials and methods: In the present work, hesperidin is identified and confirmed using chromatographic and spectral analysis. To correlate between hesperidin concentration and antioxidant capacity of peel extracts, extraction was carried out using 1% HCl-MeOH, MeOH, alkaline solution, the concentration of hesperidin determined qualitatively and quantitatively using high performance thin layer chromatography (HPTLC), high performance liquid chromatography (HPLC) analysis, in vitro antioxidant capacity of hesperidin and the extracts against free radical diphenylpicrylhydrazyl (DPPH center dot aEuro cent) performed using an electron spin resonance spectrophotometer (ESR). Cytotoxic assay against larynx, cervix, breast and liver carcinoma cell lines was performed. Results: Hesperidin was found to be moderately active as an antioxidant agent; its capacity reached 36%. In addition, the results revealed that hesperidin exhibited pronounced anticancer activity against the selected cell lines. IC50 were 1.67, 3.33, 4.17, 4.58 mu A mu g/mL, respectively. Discussion and conclusion: Orange peels are considered to be a cheap source for hesperidin which may be used in the pharmaceutical industry as a natural chemopreventive agent. Hesperidin and orange peel extract could possess antioxidant properties with a wide range of therapeutic applications.
引用
收藏
页码:276 / 282
页数:7
相关论文
共 35 条
[1]
AMIRHOSEIN A, 2008, ARCH PHARM RES, V31, P794
[2]
Bae EA, 2000, BIOL PHARM BULL, V23, P1122, DOI 10.1248/bpb.23.1122
[3]
Balbaa S.I., 1976, MED PLANTS CONSTITUE, V2nd
[4]
BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25
[5]
Additive or synergetic effects of phenolic compounds on human low density lipoprotein oxidation [J].
Cirico, TL ;
Ornaye, ST .
FOOD AND CHEMICAL TOXICOLOGY, 2006, 44 (04) :510-516
[6]
PHARMACOLOGICAL EVALUATION OF THE ANTIINFLAMMATORY ACTIVITY OF A CITRUS BIOFLAVONOID, HESPERIDIN, AND THE ISOFLAVONOIDS, DUARTIN AND CLAUSSEQUINONE, IN RATS AND MICE [J].
EMIM, JAD ;
OLIVEIRA, AB ;
LAPA, AJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (02) :118-122
[7]
Antioxidant effects of the VO(IV) hesperidin complex and its role in cancer chemoprevention [J].
Etcheverry, Susana Beatriz ;
Ferrer, Evelina Gloria ;
Naso, Luciana ;
Rivadeneira, Josefina ;
Salinas, Victoria ;
Williams, Patricia Ana Maria .
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2008, 13 (03) :435-447
[8]
FINOTTI E, 2003, NAHRAN, V47, P168
[9]
Kinetic solvent effects on phenolic antioxidants determined by spectrophotometric measurements [J].
Foti, M ;
Ruberto, G .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2001, 49 (01) :342-348
[10]
Franke AA, 1998, ADV EXP MED BIOL, V439, P237